Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by fdfd12on Mar 23, 2016 5:31pm
415 Views
Post# 24695002

CXR

CXR
earnings were short of EST at $1.24 instead of $1.30 (all in $US).

Revenue EST $166M and they had $192M.

Can't find cashflow numbers from this report.
Sedar should soon be available but it isn't now.

Basically, it was an OK Q. Not great and not guided up.
CXR has become a VERY BIG MACHINE.

CEO doens't want to guide up and take a chance.
He has never guided a plane this BIG before so he on reafirms guidance.

In conclusion, even though the stock didn't blow out numbers, it
showed that it was a good 1Q with AMCO.(70 of 90 days in Q with AMCO).

WIth numbers like these, they should be trading much higher. Take $1.24 and multiply it
by 90/70 and you get $1.60 for a full Q with AMCO.

That is $6.40 within their guidance and any reasonable multiple of 10 gets it
to $64US which is $85.

MOST important is the cashflow which is not available yet.

<< Previous
Bullboard Posts
Next >>